Critical Metals Juggles Greenland Milestone and African Ambitions Amid Cash Constraints
Investors in Critical Metals PLC are weighing the promise of two major mining projects against a rapidly shrinking…
Novo Nordisk’s Clinical Momentum Collides with Stubborn Share Price as Longevity Ambitions Take Sh
Semaglutide shows 52% sleep apnea risk reduction and anti-aging signals, but Novo Nordisk shares remain down 44% amid…
Wegovy Pill’s Gulf Debut Puts Novo Nordisk’s Global Ambitions to the Test Amid Competitive Press
Novo Nordisk expands oral Wegovy to UAE, targeting a vast untapped obesity market. Shares remain under pressure from…
Novo Nordisk’s Pipeline Ambitions Clash With Near-Term Revenue Fears as Analysts Flag 2027 Slowdow
Novo Nordisk stock up 26% but analyst warns of 3% revenue drop in 2027. Pipeline with Amycretin and…
Novo Nordisk’s AI Ambitions Clash with a Deepening Financial Downturn
Novo Nordisk braces for a major 2026 profit drop amid US pricing pressure, while investing in AI drug…
Novo Nordisk’s AI Ambitions Clash with a Deepening Financial Downturn
Novo Nordisk braces for a major 2026 profit drop amid US pricing pressure, while investing in AI drug…
European Lithium’s Greenland Ambitions Clear Final Hurdle
European Lithium’s Tanbreez project gets final approval, accelerating development of a major rare earths deposit with a secured…
European Lithium’s Greenland Ambitions Clear Final Hurdle
European Lithium’s Tanbreez project gets final approval, accelerating development of a major rare earths deposit with a secured…
Novo Nordisk’s Oral Ambitions Face a Formidable Rival and Fiscal Headwinds
Novo Nordisk touts superior weight loss & tolerability for its oral Wegovy pill vs Lilly’s Foundayo, while launching…